TVTX logo

Travere Therapeutics, Inc. (TVTX) Free cash flow

annual FCF:

-$273.69M+$48.59M(+15.08%)
December 31, 2024

Summary

  • As of today (September 16, 2025), TVTX annual free cash flow is -$273.69 million, with the most recent change of +$48.59 million (+15.08%) on December 31, 2024.
  • During the last 3 years, TVTX annual FCF has fallen by -$234.74 million (-602.79%).

Performance

TVTX Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXcash flow metrics

quarterly FCF:

-$7.34M+$46.64M(+86.41%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TVTX quarterly free cash flow is -$7.34 million, with the most recent change of +$46.64 million (+86.41%) on June 30, 2025.
  • Over the past year, TVTX quarterly FCF has increased by +$44.90 million (+85.95%).
  • TVTX quarterly FCF is now -127.49% below its all-time high of $26.69 million, reached on September 30, 2021.

Performance

TVTX quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXcash flow metrics

TTM FCF:

-$157.30M+$44.90M(+22.21%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TVTX TTM free cash flow is -$157.30 million, with the most recent change of +$44.90 million (+22.21%) on June 30, 2025.
  • Over the past year, TVTX TTM FCF has increased by +$160.47 million (+50.50%).

Performance

TVTX TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

TVTX Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+15.1%+86.0%+50.5%
3 y3 years-602.8%+84.8%-37.7%
5 y5 years-271.0%+32.6%-120.1%

TVTX Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-602.8%+15.1%at high+94.2%-37.7%+53.5%
5 y5-year-602.8%+15.1%-127.5%+94.2%-436.2%+53.5%
alltimeall time<-9999.0%+15.1%-127.5%+94.2%<-9999.0%+53.5%

TVTX Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$7.34M(-86.4%)
-$157.30M(-22.2%)
Mar 2025
-
-$53.98M(+19.2%)
-$202.19M(-26.1%)
Dec 2024
-$273.69M(-15.1%)
-$45.28M(-10.7%)
-$273.69M(-10.1%)
Sep 2024
-
-$50.70M(-2.9%)
-$304.41M(-4.2%)
Jun 2024
-
-$52.24M(-58.4%)
-$317.77M(-6.2%)
Mar 2024
-
-$125.47M(+65.1%)
-$338.67M(+5.1%)
Dec 2023
-$322.28M(+50.0%)
-$76.00M(+18.6%)
-$322.28M(+5.6%)
Sep 2023
-
-$64.06M(-12.4%)
-$305.11M(+5.9%)
Jun 2023
-
-$73.13M(-33.0%)
-$288.21M(+9.4%)
Mar 2023
-
-$109.08M(+85.4%)
-$263.35M(+22.6%)
Dec 2022
-$214.85M(+451.7%)
-$58.84M(+24.8%)
-$214.85M(+14.2%)
Sep 2022
-
-$47.16M(-2.3%)
-$188.09M(+64.6%)
Jun 2022
-
-$48.27M(-20.3%)
-$114.24M(+79.1%)
Mar 2022
-
-$60.59M(+88.9%)
-$63.79M(+63.8%)
Dec 2021
-$38.94M(-42.1%)
-$32.08M(-220.2%)
-$38.94M(+32.7%)
Sep 2021
-
$26.69M(+1119.2%)
-$29.34M(-47.8%)
Jun 2021
-
$2.19M(-106.1%)
-$56.21M(-18.9%)
Mar 2021
-
-$35.74M(+59.1%)
-$69.28M(+2.9%)
Dec 2020
-$67.31M(-8.8%)
-$22.47M(>+9900.0%)
-$67.31M(+26.3%)
Sep 2020
-
-$180.00K(-98.3%)
-$53.31M(-25.4%)
Jun 2020
-
-$10.89M(-67.8%)
-$71.47M(-14.0%)
Mar 2020
-
-$33.77M(+298.6%)
-$83.08M(+12.6%)
Dec 2019
-$73.78M(+65.2%)
-$8.47M(-53.8%)
-$73.78M(+1.4%)
Sep 2019
-
-$18.34M(-18.5%)
-$72.74M(+17.0%)
Jun 2019
-
-$22.50M(-8.1%)
-$62.14M(+34.7%)
Mar 2019
-
-$24.47M(+229.3%)
-$46.14M(+3.3%)
Dec 2018
-$44.66M(+576.0%)
-$7.43M(-4.0%)
-$44.66M(+8.9%)
Sep 2018
-
-$7.74M(+19.2%)
-$41.02M(+33.1%)
Jun 2018
-
-$6.49M(-71.8%)
-$30.82M(+36.9%)
Mar 2018
-
-$22.99M(+506.0%)
-$22.50M(+240.7%)
Dec 2017
-$6.61M
-$3.79M(-254.0%)
-$6.61M(-52.2%)
Sep 2017
-
$2.46M(+35.6%)
-$13.81M(-3.5%)
Jun 2017
-
$1.82M(-125.6%)
-$14.31M(-0.9%)
DateAnnualQuarterlyTTM
Mar 2017
-
-$7.09M(-35.5%)
-$14.45M(+6.8%)
Dec 2016
-$13.52M(+78.3%)
-$10.99M(-662.1%)
-$13.52M(+98.9%)
Sep 2016
-
$1.96M(+16.2%)
-$6.80M(-39.3%)
Jun 2016
-
$1.68M(-127.3%)
-$11.21M(+75.3%)
Mar 2016
-
-$6.17M(+44.3%)
-$6.39M(-15.7%)
Dec 2015
-$7.58M(-84.8%)
-$4.27M(+74.3%)
-$7.58M(-39.3%)
Sep 2015
-
-$2.45M(-137.7%)
-$12.49M(-51.4%)
Jun 2015
-
$6.50M(-188.3%)
-$25.69M(-45.5%)
Mar 2015
-
-$7.36M(-19.8%)
-$47.14M(-5.4%)
Dec 2014
-$49.81M(+115.3%)
-$9.18M(-41.4%)
-$49.81M(-6.0%)
Sep 2014
-
-$15.66M(+4.8%)
-$53.01M(+32.5%)
Jun 2014
-
-$14.95M(+49.0%)
-$40.02M(+46.7%)
Mar 2014
-
-$10.03M(-18.9%)
-$27.29M(+17.9%)
Dec 2013
-$23.14M(+488.8%)
-$12.37M(+363.6%)
-$23.14M(+114.8%)
Sep 2013
-
-$2.67M(+20.3%)
-$10.77M(+32.9%)
Jun 2013
-
-$2.22M(-62.3%)
-$8.10M(+37.7%)
Mar 2013
-
-$5.89M(<-9900.0%)
-$5.89M(>+9900.0%)
Dec 2012
-$3.93M(>+9900.0%)
-
-
Nov 2011
-
$0.00(0.0%)
-$600.00(-14.3%)
Aug 2011
-
$0.00(0.0%)
-$700.00(0.0%)
May 2011
-
$0.00(-100.0%)
-$700.00(0.0%)
Feb 2011
-$700.00(+600.0%)
-$600.00(+500.0%)
-$700.00(+600.0%)
Nov 2010
-
-$100.00(<-9900.0%)
-$100.00(<-9900.0%)
Aug 2010
-
$0.00(0.0%)
$0.00(-100.0%)
May 2010
-
$0.00(0.0%)
-$100.00(0.0%)
Feb 2010
-$100.00(-99.5%)
$0.00(0.0%)
-$100.00(0.0%)
Nov 2009
-
$0.00(-100.0%)
-$100.00(-66.7%)
Aug 2009
-
-$100.00(<-9900.0%)
-$300.00(+50.0%)
May 2009
-
$0.00(0.0%)
-$200.00(-99.0%)
Feb 2009
-$20.20K(<-9900.0%)
$0.00(-100.0%)
-$20.20K(0.0%)
Nov 2008
-
-$200.00(<-9900.0%)
-$20.20K(+1.0%)
Aug 2008
-
$0.00(-100.0%)
-$20.00K(0.0%)
May 2008
-
-$20.00K
-$20.00K
Feb 2008
$0.00
-
-

FAQ

  • What is Travere Therapeutics, Inc. annual free cash flow?
  • What is the all time high annual FCF for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual FCF year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly free cash flow?
  • What is the all time high quarterly FCF for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly FCF year-on-year change?
  • What is Travere Therapeutics, Inc. TTM free cash flow?
  • What is the all time high TTM FCF for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. TTM FCF year-on-year change?

What is Travere Therapeutics, Inc. annual free cash flow?

The current annual FCF of TVTX is -$273.69M

What is the all time high annual FCF for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual free cash flow is $0.00

What is Travere Therapeutics, Inc. annual FCF year-on-year change?

Over the past year, TVTX annual free cash flow has changed by +$48.59M (+15.08%)

What is Travere Therapeutics, Inc. quarterly free cash flow?

The current quarterly FCF of TVTX is -$7.34M

What is the all time high quarterly FCF for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly free cash flow is $26.69M

What is Travere Therapeutics, Inc. quarterly FCF year-on-year change?

Over the past year, TVTX quarterly free cash flow has changed by +$44.90M (+85.95%)

What is Travere Therapeutics, Inc. TTM free cash flow?

The current TTM FCF of TVTX is -$157.30M

What is the all time high TTM FCF for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high TTM free cash flow is $0.00

What is Travere Therapeutics, Inc. TTM FCF year-on-year change?

Over the past year, TVTX TTM free cash flow has changed by +$160.47M (+50.50%)
On this page